SG48953A1 - Diagnostic genes for toxoplasmosis - Google Patents

Diagnostic genes for toxoplasmosis

Info

Publication number
SG48953A1
SG48953A1 SG1996004070A SG1996004070A SG48953A1 SG 48953 A1 SG48953 A1 SG 48953A1 SG 1996004070 A SG1996004070 A SG 1996004070A SG 1996004070 A SG1996004070 A SG 1996004070A SG 48953 A1 SG48953 A1 SG 48953A1
Authority
SG
Singapore
Prior art keywords
toxoplasmosis
diagnostic genes
peptides
genetic material
genes
Prior art date
Application number
SG1996004070A
Other languages
English (en)
Inventor
John Charles Boothroyd
Lawrence James Burg
Lloyd H Kasper
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of SG48953A1 publication Critical patent/SG48953A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996004070A 1988-03-09 1989-03-03 Diagnostic genes for toxoplasmosis SG48953A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16638488A 1988-03-09 1988-03-09

Publications (1)

Publication Number Publication Date
SG48953A1 true SG48953A1 (en) 1998-05-18

Family

ID=22603069

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004070A SG48953A1 (en) 1988-03-09 1989-03-03 Diagnostic genes for toxoplasmosis

Country Status (7)

Country Link
US (2) US5629414A (de)
EP (1) EP0373192B1 (de)
JP (2) JPH02503633A (de)
AT (1) ATE139260T1 (de)
DE (1) DE68926658T2 (de)
SG (1) SG48953A1 (de)
WO (1) WO1989008700A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (de) * 1989-12-08 1991-06-13 Behringwerke Ag Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
US5215917A (en) * 1989-11-03 1993-06-01 Research Institute Of Palo Alto Medical Foundation Nucleotide sequence encoding the Toxoplasma gondii P22 gene
US5665542A (en) * 1989-11-03 1997-09-09 Research Institute Of Palo Alto Medical Foundation Toxoplasma gondii P28 gene and methods for its use
US5578453A (en) * 1990-08-10 1996-11-26 The Flinders University Of South Australia Cloning and expression of toxoplasma antigens and use of recombinant antigens
US5726152A (en) 1990-09-21 1998-03-10 Merck & Co., Inc. Vascular endothelial cell growth factor II
FR2692282B1 (fr) * 1992-06-15 1995-07-13 Pasteur Institut Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
FR2722508B1 (fr) * 1994-07-13 1996-10-04 Transgene Sa Cassette d'expression d'une proteine p30 de toxoplasma gondii
ZA958366B (en) * 1994-10-06 1996-04-24 Akzo Nobel Nv New toxoplasma gondii antigens
FR2729960A1 (fr) 1995-01-30 1996-08-02 Bio Merieux Polypeptides mimotopes de toxoplasma gondii et applications
US6399077B1 (en) * 1996-08-09 2002-06-04 Trustees Of Dartmouth College Method of augmenting T cell-mediated immunity against Toxoplasma gondii
US6993912B2 (en) * 2003-01-23 2006-02-07 Pratt & Whitney Canada Corp. Ultra low Nox emissions combustion system for gas turbine engines
WO2006094665A1 (en) 2005-03-08 2006-09-14 Kenton Srl Chimeric recombinant antigens of toxoplasma gondii
JP6673820B2 (ja) 2013-03-14 2020-03-25 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー マイクロ流体デバイスの段階的ロードのための毛細管バリア
CA3290154A1 (en) 2016-01-29 2025-11-29 Purigen Biosystems, Inc. Isotachophoresis for purification of nucleic acids
CN115569515A (zh) 2017-08-02 2023-01-06 普瑞珍生物系统公司 用于等速电泳的系统、设备和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
FR2618680B1 (fr) * 1987-07-31 1990-05-11 Pasteur Institut Antigenes d'excretion-secretion specifiques de toxoplasma gondii, leurs produits d'expression, leur procede d'obtention et leurs applications diagnostiques et prophylactiques
FR2633309B1 (fr) * 1988-06-24 1992-04-24 Pasteur Institut Sequence d'adn codant pour la proteine p30 de toxoplasma gondii, produits d'expression de cette sequence, leurs procedes d'obtention et leurs applications

Also Published As

Publication number Publication date
ATE139260T1 (de) 1996-06-15
US5859196A (en) 1999-01-12
EP0373192A1 (de) 1990-06-20
JPH02503633A (ja) 1990-11-01
WO1989008700A1 (en) 1989-09-21
DE68926658T2 (de) 1996-11-28
EP0373192A4 (en) 1990-09-05
EP0373192B1 (de) 1996-06-12
DE68926658D1 (de) 1996-07-18
US5629414A (en) 1997-05-13
JPH10210991A (ja) 1998-08-11

Similar Documents

Publication Publication Date Title
EP0373192A4 (en) Diagnostic genes for toxoplasmosis
GR880300131T1 (en) Diagnostic methods for detecting lymphomas in humans
IL90893A0 (en) Light diffraction assay using dna sequences as probes,manufacture of dna such probes and reagents therefor
AU2913789A (en) The use of volume exclusion agents for the enhancement of in situ hybridization
ZA881685B (en) Rapid hybridization assay using latex-immobilized probe
IL90990A0 (en) Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof
AU591461B2 (en) Peptide antibodies and their use in detecting oncogene products
CA2079454A1 (en) Steroid 5.alpha.-reductases
IL71699A0 (en) Methods and kits for the analysis and detection of biological or genetic material
IL81695A (en) Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination
EP0240341A3 (en) Antigens, antibodies and methods for the identification of metastatic human tumors, and cell lines for producing said antibodies
AU2182588A (en) Immunoassay and biological constructs for use therein
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
CA2067797A1 (en) Production and use of human nm23 protein and antibodies therefor
IL93661A0 (en) Endometriosis diagnosis and kits and reagents therefor
GR860229B (en) Monoclonal antibody against a ras oncogene p21 relatied dodecapeptide
GR3022080T3 (en) T-cell receptor gene located within alpha locus and dna constructions
ZA907858B (en) Differential diagnostic assay for brucellosis
JPS6416851A (en) Composition based on fluoroelastomer and modified olefin polymer
CA2013544A1 (en) Retinoblastoma gene product antibodies and uses therefor
DE3279949D1 (en) Novel microorganisms of the genus eschericia, hybrid dna for use in their production and the use of the microorganisms in the preparation of glutathione
Wheeler Stratigraphy and sedimentology of the Tensleep sandstone, southeast Bighorn Basin, Wyoming
ZA849595B (en) Hybridization assay employing labeled probe and anti-hybrid
GB8414363D0 (en) Carrying out clinical chemical and biological testing
EP0423235A4 (en) Improved biosensor and the method of its use